Catheter Precision Q1 revenue up 200% to $432K; net loss cut to $1.7M; Flyte acquisition adds aviation revenue

Catheter Precision, Inc.

Q1 revenue $432K (200% YoY) driven by medical device segment (+73%) and new Flyte aviation platform.
Net loss narrowed to $1.7M from $4.0M in Q1 2025; includes ~$560K non-cash charges.
Flyte acquisition generated $200K monthly revenue run rate within 22 days; fleet expanding to 5 jets by end of Q2 2026.
Medical device products in 15 countries; new clinical data on VIVO and LockeT presented at HRS congress.
Company now a dual-engine growth platform combining medical devices and aviation infrastructure.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.